Daiichi Sankyo And GSK Build Japanese Vaccine Firm, While Takeda Expands Abroad
This article was originally published in The Pink Sheet Daily
Executive Summary
Both Daiichi Sankyo and Takeda claim to have a path for the top vaccine spot in Japan, but all vaccine firms seem poised to benefit from MHLW's more generous attitude toward preventative medicine.